Secondary amenorrhea in a β‐thalassemia major patient treated with thalidomide
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Yang Yu, Kun Yang |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Comment on: Severe β‐thalassemia (Hb Zunyi) mimicking congenital dyserythropoietic anemia—The deceivingly normal mean corpuscular volume and hemoglobin electrophoresis in dominantly inherited β‐thalassemia: Hb Little Venice
by: Anselm Chi‐wai Lee, et al.
Published: (2024)
by: Anselm Chi‐wai Lee, et al.
Published: (2024)
Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor‐specific antibody prior to haploidentical transplantation
by: Nuttra Suwantarat, et al.
Published: (2024)
by: Nuttra Suwantarat, et al.
Published: (2024)
Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?
by: Gian Luca Forni, et al.
Published: (2024)
by: Gian Luca Forni, et al.
Published: (2024)
Pancreatic iron in pediatric transfusion‐dependent beta‐thalassemia patients: A longitudinal MRI study
by: Antonella Meloni, et al.
Published: (2024)
by: Antonella Meloni, et al.
Published: (2024)
Pediatric patients with von Hippel–Lindau and hemangioblastomas treated successfully with belzutifan
by: Emily Duan, et al.
Published: (2024)
by: Emily Duan, et al.
Published: (2024)
Single centre experience of the use of emicizumab in previously untreated and minimally treated patients under 18 months of age
by: Eman Hassan, et al.
Published: (2024)
by: Eman Hassan, et al.
Published: (2024)
Neonatal leukemia harboring KAT6A::EP300 fusion: To treat or not to treat?
by: Flavia Gava, et al.
Published: (2024)
by: Flavia Gava, et al.
Published: (2024)
Clinical features and outcomes of young patients with low‐grade non‐rhabdomyosarcoma soft tissue sarcomas treated with a risk‐based strategy: A report from Children's Oncology Group study ARST0332
by: David P. Douglass, et al.
Published: (2024)
by: David P. Douglass, et al.
Published: (2024)
Rare Findings of Spleen Lesions Secondary to Epstein–Barr Virus‐Associated Hemophagocytic Lymphohistiocytosis in Children
by: Zhengli Shan, et al.
Published: (2025)
by: Zhengli Shan, et al.
Published: (2025)
Bone marrow hematoidin crystals in a pediatric patient with chondroblastic osteosarcoma
by: Yun Zhang, et al.
Published: (2024)
by: Yun Zhang, et al.
Published: (2024)
Sustained Remission of Relapsed Extranodal NK/T‐Cell Lymphoma After Treatment With Camrelizumab Plus P‐GEMOX and Autologous Stem Cell Transplantation: A Case Report
by: Kun Yang, et al.
Published: (2024)
by: Kun Yang, et al.
Published: (2024)
Successful Use of Maribavir for Secondary CMV Prophylaxis in a Pediatric HSCT Patient
by: Joshua Broadman, et al.
Published: (2025)
by: Joshua Broadman, et al.
Published: (2025)
Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531
by: Erin K. Barr, et al.
Published: (2024)
by: Erin K. Barr, et al.
Published: (2024)
Adolescent with primary cutaneous follicle center lymphoma treated with rituximab
by: Kaitlin J. Devine, et al.
Published: (2024)
by: Kaitlin J. Devine, et al.
Published: (2024)
Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T‐lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia
by: Wallace Bourgeois, et al.
Published: (2024)
by: Wallace Bourgeois, et al.
Published: (2024)
Correction to “Successful Use of Maribavir for Secondary CMV Prophylaxis in a Pediatric HSCT Patient”
Published: (2025)
Published: (2025)
Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy
by: Ariel Nash, et al.
Published: (2024)
by: Ariel Nash, et al.
Published: (2024)
Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma
by: Ya‐Hsuan Chang, et al.
Published: (2024)
by: Ya‐Hsuan Chang, et al.
Published: (2024)
Cost‐effectiveness of treating childhood acute myeloid leukemia at a tertiary care center in North India
by: Shyam Srinivasan, et al.
Published: (2024)
by: Shyam Srinivasan, et al.
Published: (2024)
Comment on: Cost‐effectiveness of treating childhood acute myeloid leukemia at a tertiary care center in North India
by: Manraj Singh Sra, et al.
Published: (2024)
by: Manraj Singh Sra, et al.
Published: (2024)
Incorporating innovative B‐cell targeting therapeutics into a combined‐modality bridging approach followed by timely consolidative haploidentical transplantation to salvage a pediatric patient with relapsed/refractory diffuse large B‐cell lymphoma
by: Yu‐Ju Chao, et al.
Published: (2024)
by: Yu‐Ju Chao, et al.
Published: (2024)
Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide
by: Caroline Donzé, et al.
Published: (2024)
by: Caroline Donzé, et al.
Published: (2024)
Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies
by: Nathan J. Schloemer, et al.
Published: (2024)
by: Nathan J. Schloemer, et al.
Published: (2024)
Symptomatic osteonecrosis in children treated for Hodgkin lymphoma: A population‐based study in Sweden, Finland, and Denmark
by: Mia Giertz, et al.
Published: (2024)
by: Mia Giertz, et al.
Published: (2024)
BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt‐associated ascites in pediatric low‐grade gliomas
by: Nisreen Amayiri, et al.
Published: (2024)
by: Nisreen Amayiri, et al.
Published: (2024)
Multifocal Nodular Fatty Infiltration of the Liver in a Child—A Benign Condition Masquerading as a Malignant Liver Tumor
by: Yu Lin, et al.
Published: (2026)
by: Yu Lin, et al.
Published: (2026)
Controlled Red Blood Cell Apheresis as a Pretreatment of Hepatic Peliosis Resection Surgery for Severe Polycythemia Secondary to Hepatic Peliosis in a Child
by: Chun‐Xi Wu, et al.
Published: (2025)
by: Chun‐Xi Wu, et al.
Published: (2025)
KIT ‐mutated pediatric core‐binding factor systemic mastocytosis‐acute myeloid leukemia treated with avapritinib and decitabine
by: Irtiza N. Sheikh, et al.
Published: (2024)
by: Irtiza N. Sheikh, et al.
Published: (2024)
Socioeconomic Status and Stroke Risk in Pediatric Sickle Cell Disease: A DISPLACE Study Secondary Analysis
by: Jeffrey G. Edwards, et al.
Published: (2025)
by: Jeffrey G. Edwards, et al.
Published: (2025)
Sequelae and post‐thrombotic syndrome after venous thromboembolism in acute lymphoblastic leukemia survivors treated on the NOPHO ALL2008 protocol
by: Merete Dam, et al.
Published: (2024)
by: Merete Dam, et al.
Published: (2024)
A Rare Case of Pediatric Hepatocellular Carcinoma Secondary to Mitochondrial DNA Depletion Syndrome Type 3 ( DGUOK Mutation)
by: Tejasvi R, et al.
Published: (2026)
by: Tejasvi R, et al.
Published: (2026)
Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group
by: Jonathan Metts, et al.
Published: (2024)
by: Jonathan Metts, et al.
Published: (2024)
Coexistence of MYCN ‐activating mutation and amplification in a patient with neuroblastoma
by: Masato Kojima, et al.
Published: (2024)
by: Masato Kojima, et al.
Published: (2024)
Fatal EBV‐Associated Posttransplant Lymphoproliferative Disease and Secondary Hemophagocytic Lymphohistiocytosis in a Pediatric Patient With Hurler Syndrome Following Hematopoietic Cell Transplantation: A Case Report and Review of the Literature
by: Florian Gierse, et al.
Published: (2025)
by: Florian Gierse, et al.
Published: (2025)
BRAF‐V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first‐line therapy
by: Chan‐Juan Wang, et al.
Published: (2024)
by: Chan‐Juan Wang, et al.
Published: (2024)
Treatment of a pediatric patient with concurrent neuroblastoma and acute lymphoblastic leukemia
by: Megan M. Lilley, et al.
Published: (2024)
by: Megan M. Lilley, et al.
Published: (2024)
PD‐L1 Expression is Mediated by microRNA Processing, Wnt/β‐Catenin Signaling, and Chemotherapy in Wilms Tumor
by: Patricia D. B. Tiburcio, et al.
Published: (2025)
by: Patricia D. B. Tiburcio, et al.
Published: (2025)
Exogenous steroid replacement in a pediatric patient with adrenocortical carcinoma receiving mitotane
by: Catherine E. Martin, et al.
Published: (2024)
by: Catherine E. Martin, et al.
Published: (2024)
Fibrin‐associated diffuse large B‐cell lymphoma in a pediatric patient
by: Paige Reilly, et al.
Published: (2024)
by: Paige Reilly, et al.
Published: (2024)
Feasibility of multimodal therapy for rhabdomyosarcoma in a patient with Fukuyama congenital muscular dystrophy
by: Masanaka Sugiyama, et al.
Published: (2024)
by: Masanaka Sugiyama, et al.
Published: (2024)
Similar Items
-
Comment on: Severe β‐thalassemia (Hb Zunyi) mimicking congenital dyserythropoietic anemia—The deceivingly normal mean corpuscular volume and hemoglobin electrophoresis in dominantly inherited β‐thalassemia: Hb Little Venice
by: Anselm Chi‐wai Lee, et al.
Published: (2024) -
Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor‐specific antibody prior to haploidentical transplantation
by: Nuttra Suwantarat, et al.
Published: (2024) -
Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?
by: Gian Luca Forni, et al.
Published: (2024) -
Pancreatic iron in pediatric transfusion‐dependent beta‐thalassemia patients: A longitudinal MRI study
by: Antonella Meloni, et al.
Published: (2024) -
Pediatric patients with von Hippel–Lindau and hemangioblastomas treated successfully with belzutifan
by: Emily Duan, et al.
Published: (2024)